Literature DB >> 4200532

Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis.

W T Hughes, H K Kim, R A Price, C Miller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4200532

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


× No keyword cloud information.
  11 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Pneumocystis carinii: A review of an important opportunistic pathogen in AIDS.

Authors:  M J Gill; R Read
Journal:  Can J Infect Dis       Date:  1991

3.  Propagation of Pneumocystis carinii in Vero cell culture.

Authors:  L L Pifer; D Woods; W T Hughes
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

4.  Combination of pentamidine and trimethoprim-sulfamethoxazole in therapy of Pneumocystis carinii pneumonia in rats.

Authors:  R M Kluge; D M Spaulding; A J Spain
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

5.  Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; R D Powell; K Yoneda; M E Rutledge; J E Milder
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

6.  Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.

Authors:  W T Hughes
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

Review 7.  Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia.

Authors:  K L Goa; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

8.  Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia.

Authors:  C K Kim; J M Foy; M T Cushion; D Stanforth; M J Linke; H L Hendrix; P D Walzer
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

9.  Predisposing factors in Pneumocystis carinii pneumonia: effects of tetracycline, protein malnutrition, and corticosteroids on hosts.

Authors:  P D Walzer; M LaBine; T J Redington; M T Cushion
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

10.  Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; P C McNabb; T D Makres; S Feldman
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.